Cargando…

Oral anticoagulant therapy for patients with new-onset atrial fibrillation following acute myocardial infarction: A narrative review

BACKGROUND: To evaluate the advantages and disadvantages of anticoagulant therapy and provide a piece of information on anti-thrombotic treatment strategies for patients with new-onset atrial fibrillation (NOAF) and acute myocardial infarction (AMI). METHODS: Literature from PubMed and Google schola...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shenglong, Li, Chenxi, Guo, Huizhuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669747/ https://www.ncbi.nlm.nih.gov/pubmed/36407466 http://dx.doi.org/10.3389/fcvm.2022.1046298

Ejemplares similares

New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke
por: Lee, Ji Hyun, et al.
Publicado: (2020)

Prognostic Impact of the Symptom of New-Onset Atrial Fibrillation in Acute Myocardial Infarction: Insights From the NOAFCAMI-SH Registry
por: Luo, Jiachen, et al.
Publicado: (2021)

Stress hyperglycemia ratio and neutrophil to lymphocyte ratio are reliable predictors of new-onset atrial fibrillation in patients with acute myocardial infarction
por: Pan, Lifei, et al.
Publicado: (2022)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review
por: Adelakun, Adenike R, et al.
Publicado: (2023)

Association Between Fasting Hyperglycemia and New-Onset Atrial Fibrillation in Patients With Acute Myocardial Infarction and the Impact on Short- and Long-Term Prognosis
por: Li, Mingxing, et al.
Publicado: (2021)

Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
por: Li, Zhitong, et al.
Publicado: (2022)

A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation
por: Mai, Linlin, et al.
Publicado: (2019)

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

Sex differences in ventricular arrhythmia, atrial fibrillation and atrioventricular block complicating acute myocardial infarction
por: Alnsasra, Hilmi, et al.
Publicado: (2023)

Implications of new-onset atrial fibrillation on in-hospital and long-term prognosis of patients with acute myocardial infarction: A report from the CBD bank study
por: Yang, Wang-Yang, et al.
Publicado: (2022)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2022)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
por: Li, Wenhao, et al.
Publicado: (2022)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation
por: Gong, Xiaoxian, et al.
Publicado: (2022)

Association of soluble suppression of tumorigenicity 2 protein with new-onset atrial fibrillation in patients with acute ST-segment elevation myocardial infarction undergoing primary PCI
por: Zhao, Ting-ting, et al.
Publicado: (2023)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

Triglyceride-Glucose Index and New-Onset Atrial Fibrillation in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention
por: Ling, Yang, et al.
Publicado: (2022)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
por: Liu, Xuyang, et al.
Publicado: (2022)

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2022)

Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage
por: Liu, Xin, et al.
Publicado: (2022)

Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
por: Guo, Guigao, et al.
Publicado: (2022)

Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry
por: Lee, Oh-Hyun, et al.
Publicado: (2021)

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States
por: Deitelzweig, Steven, et al.
Publicado: (2020)

World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
por: Murphy, Aileen, et al.
Publicado: (2020)

Clinical benefits of oral anticoagulants in atrial fibrillation patients with dementia: a systematic review and meta-analysis
por: Wang, Dayang, et al.
Publicado: (2023)

Effects of direct oral anticoagulants vs. vitamin K antagonists on acute kidney injury in patients with atrial fibrillation: A systematic review
por: Ren, Chengfa, et al.
Publicado: (2023)

Case Report: Acute Renal and Splenic Infarctions Secondary to Atrial Fibrillation
por: Yihan, Li, et al.
Publicado: (2022)

Left atrial function after standalone totally thoracoscopic left atrial appendage exclusion in atrial fibrillation patients with absolute contraindication to oral anticoagulation therapy
por: Marini, Massimiliano, et al.
Publicado: (2022)

Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies
por: Salmasi, Shahrzad, et al.
Publicado: (2020)

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
por: Choi, Ju Hee, et al.
Publicado: (2022)

Safety and Effectiveness of Direct Oral Anticoagulants vs. Warfarin in Patients With Atrial Fibrillation and Endoscopy-Diagnosed Peptic Ulcer
por: Wang, Chun-Li, et al.
Publicado: (2021)

Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Elfar, Sohil, et al.
Publicado: (2022)

Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016
por: Maura, Géric, et al.
Publicado: (2019)

Survival benefits of oral anticoagulation therapy in acute kidney injury patients with atrial fibrillation: a retrospective study from the MIMIC-IV database
por: Bo, Dan, et al.
Publicado: (2023)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
por: Liu, Fuwei, et al.
Publicado: (2021)

Effectiveness of Direct Oral Anticoagulants in Obese Adults With Atrial Fibrillation: A Systematic Review of Systematic Reviews and Meta-Analysis
por: Shaikh, Fahad, et al.
Publicado: (2021)

Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2022)

Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Rhee, Tae-Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2voeptcgbukc0lc13q317qe84e